EDGAR Filing Documents for 0001493152-20-021154

Form 8-K - Current report:

SEC Accession No. 0001493152-20-021154

Filing Date

2020-11-12

Accepted

2020-11-12 17:26:54

Documents

Period of Report

2020-11-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	90727
2		ex2-1.htm	EX-2.1	754158
3		ex2-2.htm	EX-2.2	77923
4		ex2-3.htm	EX-2.3	79348
5		ex4-1.htm	EX-4.1	111219
6		ex4-2.htm	EX-4.2	110449
7		ex10-1.htm	EX-10.1	24015
8		ex10-2.htm	EX-10.2	150218
9		ex10-3.htm	EX-10.3	279476
10		ex10-4.htm	EX-10.4	43570
11		ex99-1.htm	EX-99.1	38841
	Complete submission text file	0001493152-20-021154.txt		1761222

Mailing Address 201 GROVE RD THOROFARE NJ 08086

Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698

Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)